Dr. Josef Neu, MD, did his medical school training at the University of Wisconsin, was a pediatric resident at Johns Hopkins and a postdoctoral neonatology fellow at Stanford University. He came to the University of Florida as an associate professor in 1984 to continue his research in developmental gastroenterology and neonatal biochemical nutrition. In 1987 he pursued additional research training at the University of Bern (Switzerland) on basic mechanisms affecting intracellular processing of lactase in the intestinal epithelium. He is internationally recognized for his research in developmental gastroenterology and nutrition and has most recently focused his research efforts on the developing intestinal microbiome and host interactions.  He is currently NIH RO-1 funded to study the developing microbiome and to discover biomarkers in babies at risk for developing necrotizing enterocolitis. This involves a multicenter evaluation of intestinal microbiota using novel non-culture based technologies. Another project involves evaluation of a novel dipeptide on the prevention of retinopathy of prematurity and oxygen induced injury to the intestine, lung and brain. He has several patents and patents pending in the area of nutritional supplementation for low birthweight infants.

Dr Neu maintains an active interest in residency and fellowship training. He has served as director of the neonatology fellowship training program at UF since 1986 and on the Council for the Organization of Neonatal Training Program Directors (ONTPD) for the past three years and is past Chair of the ONTPD. He is on the editorial board of 7 journals, has served on numerous NIH study sections and is also active in international education; as a member of International Postgraduate Organization for Knowledge Transfer Research and Teaching Excellent Students (IPOKRaTES), he has organized seminars in neonatal gastroenterology and nutrition in Turkey, Italy, Poland, Georgia, Latvia, Slovenia, Portugal, Mexico United Arab Emirates, and Brazil. He has also lectured in various countries in Europe, China, Japan, Canada, United Arab Emirates, Egypt, Saudi Arabia, Kuwait, and Venezuela. He was the first US pediatrician involved as an external examiner for medical students at the Chinese University of Hong Kong.

Dr. Neu has been involved in the mentorship of over 20 postdoctoral M.D. neonatology fellows, a pediatric gastroenterology fellow, approximately 15 visiting international scholars, 2 Ph.D. postdoctoral fellows, over 20 undergraduate independent study students (the majority of whom have gone on to medical, veterinary or graduate school in the sciences). He has also mentored 15 high school students in his laboratory.

Lyn Chitty is in the unique position of being the only Professor of Genetics and Fetal Medicine in the UK, and was appointed to this chair at the Institute of Child Health, University College London in 2009; she is also a Consultant in the Fetal Medicine Unit at University College Hospital NHS Foundation Trust. She has published extensively on prenatal diagnosis, and the ultrasound screening of fetal abnormalities, specifically fetal skeletal abnormalities, and was responsible for the creation of the fetal size standards now in use throughout the UK and beyond.    Her main current research interest is in non-invasive prenatal diagnosis and she leads a five-year programme grant from the National Institute of Health Research (Rapid Accurate Prenatal non-Invasive Diagnosis (RAPID) – an integrated project to refine and implement safer antenatal testing) which is designed to develop the standards for routine implementation of this exciting new technology.  She was a member of the National Screening Committee on Routine Fetal Anomaly Scanning for some years.  She is also an editor of the journal, Prenatal Diagnosis, and is on the Board of Directors of the International Society of Prenatal Diagnosis.  She has recently been appointed as the Clinical Director of the NIHR Clinical Research Network: North Thames.

Paul Griffiths has been the Professor of Radiology at the University of Sheffield since 1996.  He did his undergraduate and Radiology training in Manchesteras well as his PhD in Experimental Neurology.  He completed his sub-speciality training in Neuroradiology in Newcastle and then worked at the Hospital for Sick Children,Torontoas their first International Neuroradiology Scholar in 1994.  He is a paediatric neuroradiologist with major research interests in the developing central nervous system. 

Andrew Hattersley qualified fromOxfordin 1984. He trained in Diabetes at the Hammersmith Hospital, Oxford and Birmingham before taking up his present post as a consultant diabetologist in Exeter in 1995.

His principal area of research is the molecular genetics of diabetes with a particular emphasis on monogenic diabetes.  He has takenExeterfrom a centre without a genetics laboratory to being a leading international centre for both monogenic diabetes and Type 2 diabetes. He is the Professor of Molecular Medicine at the Peninsula Medical School. .

Exeterhas the largest international collections of both maturity-onset diabetes of the young and neonatal diabetes.  Their work has been from “bench to bedside” identifying novel genes, characterizing the associated clinical syndromes, defining the pathophysiology and developing the best clinical care. 

Neena Modi is Professor of Neonatal Medicine, Imperial College London, Consultant in Neonatal Medicine, Chelsea & Westminster Hospital, London, and President of the UK Neonatal Society. 

Neena qualified from the University of Edinburgh, followed by specialist training in neonatal medicine at University College Hospital London, and the University of Liverpool. She is a practising clinician and academic lead of a multidisciplinary neonatal research programme with a focus on nutritional and other perinatal determinants of life-long metabolic health. In 2007 she led the establishment of the Neonatal Data Analysis Unit and in 2012, the UK Neonatal Collaborative, with the aim of developing the use of clinical electronic data to support neonatal services and research.

Neena contributes to neonatal services in several expert advisory and national leadership roles, including Chair of the British Medical Journal Ethics Committee and NHS England Infant, Children’s and young People’s Patient Safety Expert Group. She directs the well-known “Neonatal Update: the science of newborn care”, a week-long international academic meeting held in London each year

Fionnuala McAuliffe is a Professor of Obstetrics and Gynaecology with a special interest in maternal and fetal medicine at National Maternity Hospital Dublin. She is Head of Women’s and Child’s Health at University College Dublin. Areas of interests include Obstetrics, Maternal and Fetal Medicine, diabetic  and obese pregnancy, prenatal ultrasound and fetal cardiology. She has received significant grant funding both nationally and internationally and has more than 130 peer reviewed publications. Recent research has focused on maternal nutrition in pregnancy and impact on mother and baby health. She is the principal Investigator on the ROLO study which is a large randomised trial examining the impact of a low glycaemic diet on maternal and fetal health,  and is currently following these children to 5 years of age.

She qualified in Medicine at University College Dublin and then undertook training in Ireland, London, UK  and in Toronto, Canada. She is a Fellow of the Royal College of Obstetricians & Gynaecologists UK, Fellow of the Royal College of Physicians of Ireland. She holds many committee positions at the RCPI, is a reviewer for over 10 international scientific journals and has developed guidelines for pregnancy both in Ireland and in the UK and is an executive member of the Maternal Medicine Clinical Studies Group in the UK.

Irene Roberts has been Professor of Paediatric Haematology at the University of Oxford since October 2013. She was previously at Imperial College London where she spent 25 years as Senior Lecturer, then Professor, of Paediatric Haematology. She has longstanding research interests in fetal and neonatal haematology, focusing over the last 10 years on the impact of trisomy 21 on fetal haematopoiesis and haematological problems in children with Down syndrome.


David Haslam is Chair of the National Institute for Health and Care Excellence. He is also past-President of the British Medical Association, past-President of the Royal College of General Practitioners, and visiting Professor in Primary Health Care at de Montfort University, Leicester. He was a GP in Ramsey, Cambridgeshire, for many years and has been chair of the NHS Evidence Advisory Committee, co-chair of the NHS Future Forum Information subgroup, an expert member of the NHS National Quality Board, chair of the NQB Quality Information Committee, and National Clinical Adviser to both the Care Quality Commission and the Healthcare Commission. He is a Fellow of the Royal College of GPs, a Fellow of the Faculty of Public Health, a Fellow of the Academy of Medical Educators, and a Fellow of the Royal College of Physicians. David was Chairman of Council of the RCGP from 2001 to 2004, and was also a member of the NHS Modernisation Board, vice chairman of the Academy of Medical Royal Colleges, a member of the Postgraduate Medical Education Training Board, a member of NHS Medical Education England, a member of the RCP’s Future Hospital Commission, and co-chair of the MMC Programme Board from 2006-9. He has written 13 books, mainly on health topics for the lay public and translated into 13 languages, and well over a thousand articles for the medical and lay press. He was awarded the CBE in 2004 for services to Medicine and Health Care.

Francis de Zegher graduated in Medicine at the University of Leuven (Belgium) in 1981 and was a Resident in Paediatrics at Sophia Children's Hospital in Rotterdam (the Netherlands) and a Fellow in Paediatric Endocrinology at the University of California in San Francisco (USA) before returning to Leuven in 1988. Professor de Zegher gave lectures for and received awards from the Endocrine Society and international Societies in Pediatric Endocrinology, and is a Member of the Royal Academy of Medicine (Belgium). Current research interests include androgen excess, immunometabolism, and the early-life endocrinology of elite athletes.

Stephen Robson MB BS MRCOG MD is Professor of Fetal Medicine and a member of the Institute of Cellular Medicine at Newcastle University.  After graduating from Newcastle University he undertook further training in Obstetrics and Gynaecology in the Northern Region of England. He was subsequently appointed to a Lectureship at the RPMS Institute of Obstetrics and Gynaecology at Queen Charlotte’s and Chelsea Hospital in London after which he was awarded a RCOG Subspecialty Training Fellowship. After completing subspecialty training at University College Hospital, London, he returned to Newcastle University as Senior Lecturer, prior to being appointed Professor of Fetal Medicine in 1994. His main research interests are: uterine cell signalling, mechanisms of myometrial quiescence and clinical trials in the area of high risk pregnancy and prenatal screening. He has been involved in the development and audit of national guidelines relating to obstetric care and is Clinical Director of the NIHR CRN: North East and North Cumbria.

Stephen G. Matthews is Professor of Physiology, Obstetrics and Gynecology and Medicine at the University of Toronto. He is also the Ernest B. and Leonard B. Smith Professor and Chair of the Department of Physiology. Professor Matthews received his undergraduate education at the University of Nottingham, and his PhD from the University of Cambridge, UK. He was appointed to the University of Toronto in 1996.

His research is focused towards understanding how alterations in the fetal environment can affect developmental trajectories leading to permanent modification of endocrine function and behaviour. His recent research has established that the effects of such environmental manipulation can extend across multiple generations. With a focus on epigenetics, his research team is determining the molecular mechanisms by which such ‘programming’ can occur. In a parallel program of study, his group is investigating drug and hormone transport mechanisms in the placenta and fetal brain, with a focus on developing novel treatments that modulate drug transport at these two sites.

Professor Matthews is committed to translating fundamental research to a human context. In this regard, he was founding co-director of the MAVAN program, which follows the neurocognitive development of infants and children following adverse early experience. He was also one of the founding investigators on the MACS program that followed pregnancy outcomes and neurocognitive development in children exposed to glucocorticoids in pregnancy. He has published over 170 scientific papers, is regularly invited to present his work around the world and is involved in a number of international research initiatives.

Allyson Pollock is Professor of Public Health Research & Policy at Queen Mary, University of London. She is one of the UK’s leading medical intellectuals, and undertakes research and teaching intended to assist the realisation of the principles of social justice and public health, with a particular emphasis on health systems research, trade, and pharmaceuticals. She trained in medicine in Scotland and became a consultant in public health. Among her previous roles she has been director of the Centre for International Public Health Policy at the University of Edinburgh and director of research & development at UCL Hospitals NHS Trust. She is the author of NHS plc and co-author of The New NHS: a guide.

Scott Nelson was appointed directly to the Muirhead Chair in Obstetrics and Gynaecology at the University of Glasgow in August 2008 on completion of his specialist training.  He had previously undertaken his medical training in Glasgow with a PhD in fetal therapy from the University of Dundee.  Further clinical academic training was undertaken in Glasgow as a SHEFC Clinician Scientist in maternal medicine and assisted conception prior to gaining his CCT.  Professors Nelson’s clinical interest is the interface of assisted conception and perinatal medicine, with his research focusing on reproductive health across the lifecourse.

Simon Eccles a craniofaical surgeon working at the Chelsea and Westminster Hospital. I trained das a dentist then as a Doctor, before beginning my training as a plastic and craniofacial surgeon. My interests are head shape anomalies and reconstruction of complex craniofacial anomalies. I am a trustee and surgeon working for Facing the World, a charity that treats children with facial deformity from a round the world. I am the clinical director of children’s services at the Chelsea and Westminster hospital, I lead the childrens strategic surgery group for London and sit on the paediatric specialist commissioning group for NHS England

Dr Phillip Gordon received his undergraduate degree in psychology from North Carolina State University (including a year abroad at what was thenPlymouth Polytechnic). He received his PhD from Florida State University in Molecular Biology, publishing his dissertation on high energy phosphate transfer in intestinal epithelial cells. It included the first characterization of the creatine kinase isoforms in vertebrate mucosa. He received his MD from the University of Florida and did his residency at Childrens Hospital in Seattle, in affiliation with the University of Washington. It was there that he did the controversial study that launched his career; the first to demonstrate an association between postnatal steroids and spontaneous/focal intestinal peforations. He did his neonatology fellowship at the University of North Carolina, where he established a neonatal mouse model of steroid effect on the neonatal bowel. He went on to the University of Virginia Medical Center as a young faculty, where he developed cell culture and transgenic mouse models,eventually elucidating the combined mechanisms by which steroids and NSAIDs lead to spontaneous intestinal perforations and definitively establishing spontaneous intestinal disease as an illness distinct from  that of necrotizing enterocolitis.Dr Gordon attained the rank of associate professor at the University of Virginia (where he was the neonatal fellowship director), before leaving to become the division head of neonatology at Oschner Medical System,shortly after Hurricaine Katrina decimated the city of New Orleans. Over 3 years he established Ochsner as the dominate neonatal regional service

before returning to academics at Tulane University Medical School as Professor and Associate Chair of Pediatrics (and director of their NICU system). At Tulane, Dr Gordon retooled their neonatal services on three campuses, helping to return the department to solvency. At the same time,

as the new acting co-director of the infamous Charity NICU (a "teaching" NICU for the indigent, shared between Tulane and Louisiana State Charity System), he moved quickly to force closure of the fourth because of its poor outcomes.Throughout Dr Gordon's career, he has used regional and national clinical datasets to better understand both spontaneous intestinal peforations and

necrotizing enterocolitis. Today he is the associate director of clinical research for the Pediatrix corporation,where he continues to relentlessly 1 pursue these same goals using the largest contemporary neonatal dataset in the world.

Nikki Robertson has been a consultant neonatologist at UCH for the last 10 years. She also leads the Preclinical Neonatal Neuroprotection and Neuroscience Research Group at UCL investigating new ways to protect the brain in neonatal encephalopathy. Her team consists of basic neuroscientists, physicists and neonatologists and she focuses on magnetic resonance biomarker development and validation in both her preclinical model and in babies. Her 10 year vision is to develop a balanced therapy of compatible and complementary neuroprotective interventions that can be combined with maximal safety and efficacy; the aim is that this combination can then translate to the clinic to improve neurodevelopmental outcomes after perinatal asphyxia in all settings across the world.